澳大利亚-新西兰子宫内膜症、大麻与保险患者数据集
一项针对澳大利亚和新西兰子宫内膜症患者使用大麻/大麻素管理症状的问卷调查数据集，涵盖疾病严重程度、生活质量、保险和法律影响。
基本信息
资源简介
澳大利亚-新西兰子宫内膜症、大麻与保险患者数据集
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 372.34 KB，主题涵盖 cannabis、endometriosis、tetrahydrocannabinol、THC、CBD，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Patients AU-NZ_ Endometriosis, Cannabis and Insurance - February 2, 2023 - Be Damned Paper.xlsx》。源站首次发布：2024-11-28。
【数据内容】
源站原始描述：The study was approved by Western Sydney University Human Research Ethics Committee (approval number H15099): An online, anonymous, cross-sectional survey was hosted on Qualtrics and was open between October- December 2022. Researchers recruited respondents through social media and email distribution to one of Australia’s largest medicinal cannabis advocacy platforms (Cannareviews.co). Inclusion criteria were women (and those assigned female at birth) aged 18 years or older; had a diagnosis of e…
【数据结构与技术规格】
文件数 1 个，合计 372.34 KB。Be Damned Paper.xlsx：application/vnd.openxmlformats-officedocument.spreadsheetml.sheet，372.34 KB。数据集 DOI：10.6084/m9.figshare.27925425.v1。
【主题与分类】
源站学科分类：Commercial law not elsewhere classified、Commercial law、Medical and health law、Law and society and socio-legal research、Law reform、Law, gender and sexuality (incl. feminist legal scholarship)。主题标签：cannabis、endometriosis、tetrahydrocannabinol、THC、CBD、insurance、life insurance、trauma insurance、TPD、Total and permanent disability。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://figshare.com/articles/dataset/Patients_AU-NZ_Endometriosis_Cannabis_and_Insurance_-_February_2_2023_-_Be_Damned_Paper_xlsx/27925425
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Proudfoot, Andrew (2024). Patients AU-NZ_ Endometriosis, Cannabis and Insurance - February 2, 2023 - Be Damned Paper.xlsx. figshare. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Patients AU-NZ_ Endometriosis, Cannabis and Insurance - February 2, 2023 - Be Damned Paper.xlsx
- DOI：10.6084/m9.figshare.27925425.v1
- 发布日期：2024-11-28
- 文件数：1 个
- 文件总体积：372.34 KB
- 源站页面：https://figshare.com/articles/dataset/Patients_AU-NZ_Endometriosis_Cannabis_and_Insurance_-_February_2_2023_-_Be_Damned_Paper_xlsx/27925425
命令行下载
curl -L -o "Be Damned Paper.xlsx" "https://ndownloader.figshare.com/files/50862606"
文件清单
Be Damned Paper.xlsx（372.34 KB）
文件总体积 372.34 KB（源站 API 实测）。
数据说明
The study was approved by Western Sydney University Human Research Ethics Committee (approval number H15099): An online, anonymous, cross-sectional survey was hosted on Qualtrics and was open between October- December 2022. Researchers recruited respondents through social media and email distribution to one of Australia’s largest medicinal cannabis advocacy platforms (Cannareviews.co). Inclusion criteria were women (and those assigned female at birth) aged 18 years or older; had a diagnosis of endometriosis from a doctor; were residents of Australia or New Zealand (NZ); and had consumed either illicit cannabis or a legal cannabinoid based medicinal product (CBMP) that was prescribed by a doctor (or via a clinical trial or nurse practitioner), after 1 November 2016, to manage endometriosis and chronic pelvic pain related symptoms. Informed consent was obtained from all participants, with the survey introduction and participant information sheet stating that completion of the questionnaire implied consent. The 88-question survey was developed by the research team and collected information on the severity of endometriosis and health-related quality of life in those with endometriosis who consume cannabinoids and explored insurance and law related issues including the self-reported impact of cannabis and CBMP on the use of other legal drugs and disclosure to primary doctor and life insurers.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.27925425.v1（source: https://figshare.com/articles/dataset/Patients_AU-NZ_Endometriosis_Cannabis_and_Insurance_-_February_2_2023_-_Be_Damned_Paper_xlsx/27925425）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
